Prevention of Central Line–Associated Bloodstream Infections

The author reviews the patient, provider, and device factors that contribute to central line–associated bloodstream infections and discusses preventive strategies.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2023-09, Vol.389 (12), p.1121-1131
1. Verfasser:	O’Grady, Naomi P.
Format:	Artikel
Sprache:	eng
Schlagworte:	and the FDA Antibiotics Bacterial Infections Biofilms Cardiology Cardiology General Catheter-Related Infections - etiology Catheter-Related Infections - prevention & control Catheterization, Central Venous - adverse effects Catheterization, Central Venous - instrumentation Catheters Central Venous Catheters - adverse effects Clinical Medicine Clinical Medicine General Coronaviruses COVID-19 Critical Care Devices Drugs Emergency Medicine Emergency Medicine General Health care policy Health Policy Hemodialysis Hospital costs Hospital-Based Clinical Medicine Humans Infectious Disease Infectious Disease General Intensive care Length of stay Medical laboratories Mortality Nosocomial infections Pandemics Pathogenesis Pathogens Patient safety Pneumonia Prevention Public policy Pulmonary Quality of Care Sepsis - etiology Sepsis - prevention & control Surgery Surgery General Viral Infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The author reviews the patient, provider, and device factors that contribute to central line–associated bloodstream infections and discusses preventive strategies.
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMra2213296